_________
false
C002
קמהדע בע"מ
2
Public
KAMADA LTD
9024
Corporation no:
511524605
Stock Exchange/Market:
-1
1934
380
Sapir 7
P.O.B 4081
,
Ness-Ziona
74036
,
ISRAEL
,
Tel:
08-9406472
,
Fax:
08-9406473
E.mail address:
liatc@kamada.com
Reported via MAGNA:
21/10/2014
Time of broadcast:
13:44
13:38:54
Company site:
www.kamada.com
Reference:
2014-02-178305
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Kamada Announces Study in Support of Alpha-1 Antitrypsin for the Treatment of Type-1 Diabetes Published in the Journal of Diabetes Science and Technology
ence_and_Technology_FI_-_final_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure:
03/09/2014
Name of the Signatory:
:
Cohen Liat
,
Position of Signatory in the reporting corporation:
Company Controller
,
Name of Employer Company:
.
Sapir
Telephone:
08-9913168
,
Facsimile:
08-9912183
,
E-mail:
liatc@kamada.com
1